Want to join the conversation?
$BIIB 2Q15 Call: Expects to pay approx. $850MM in CVR payments in 2015. Anticipates CapEx of approx. $650-700MM, an increase over 2014. Expects Phase 3 for TYSABRI in SPMS in 2015. Phase 3 for SMN-Rx expected late 2016 or early 2017. Clinical results for Phase 2 of BAN2401 and E2609 expected in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?